These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 8323255

  • 1. An assay for monitoring response to therapy in cancer patients.
    Wilhide CC, Larcom LL.
    Ann Clin Lab Sci; 1993; 23(3):207-15. PubMed ID: 8323255
    [Abstract] [Full Text] [Related]

  • 2. The response of cancer patients' lymphocytes to mitogen. The effect of indomethacin on adherent and non-adherent cells activity.
    Pituch-Noworolska A.
    Arch Immunol Ther Exp (Warsz); 1981; 29(2):161-5. PubMed ID: 7305629
    [Abstract] [Full Text] [Related]

  • 3. Increased monocyte phagocytosis and decreased lymphocyte mitogen reactivity in colorectal cancer patients.
    Ruco LP, Procopio A, Valtieri M, Uccini S, Chirletti P, Baroni CD.
    Appl Pathol; 1983; 1(3):149-56. PubMed ID: 6678592
    [Abstract] [Full Text] [Related]

  • 4. Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer.
    Rinehart J, Adjei AA, Lorusso PM, Waterhouse D, Hecht JR, Natale RB, Hamid O, Varterasian M, Asbury P, Kaldjian EP, Gulyas S, Mitchell DY, Herrera R, Sebolt-Leopold JS, Meyer MB.
    J Clin Oncol; 2004 Nov 15; 22(22):4456-62. PubMed ID: 15483017
    [Abstract] [Full Text] [Related]

  • 5. Quantitative and functional study of breast cancer axillary lymph nodes and those draining other human malignant tumors.
    Di Girolamo V, Laguens RP, Coronato S, Salas M, Spinelli O, Portiansky E, Laguens G.
    J Exp Clin Cancer Res; 2000 Jun 15; 19(2):155-9. PubMed ID: 10965811
    [Abstract] [Full Text] [Related]

  • 6. T cell-dependent antibody responses against aberrantly expressed cyclin B1 protein in patients with cancer and premalignant disease.
    Suzuki H, Graziano DF, McKolanis J, Finn OJ.
    Clin Cancer Res; 2005 Feb 15; 11(4):1521-6. PubMed ID: 15746055
    [Abstract] [Full Text] [Related]

  • 7. Demonstration of antibodies to the chitin-binding mistletoe lectin (cbML) in tumor patients before and during therapy with an aqueous mistletoe extract.
    Klein R, Franz M, Wacker R, Classen K, Scheer R, Von Laue HB, Stoeva S, Voelter W.
    Eur J Med Res; 2004 Jun 30; 9(6):316-22. PubMed ID: 15257874
    [Abstract] [Full Text] [Related]

  • 8. Statistical approach to immunosuppression classification using lymphocyte surface markers and functional assays.
    Dillman RO, Koziol JA.
    Cancer Res; 1983 Jan 30; 43(1):417-21. PubMed ID: 6847781
    [Abstract] [Full Text] [Related]

  • 9. [The effect of human cord plasma on the incorporation of 3H-thymidine by PHA-stimulated peripheral blood lymphocytes of cervical cancer patient (author's transl)].
    Fujii S, Nakashima N, Kobayashi H, Mori T, Nishimura T.
    Acta Obstet Gynaecol Jpn; 1980 Dec 30; 32(12):1945-50. PubMed ID: 7211212
    [Abstract] [Full Text] [Related]

  • 10. Combining conventional therapies with intratumoral injection of autologous dendritic cells and activated T cells to treat patients with advanced cancers.
    Mann DL, Celluzzi CM, Hankey KG, Harris KM, Watanabe R, Hasumi K.
    Ann N Y Acad Sci; 2009 Sep 30; 1174():41-50. PubMed ID: 19769735
    [Abstract] [Full Text] [Related]

  • 11. Lymphocyte response to PHA and patient response to chemotherapy in breast cancer.
    Jones KD, Whitehead RH, Grimshaw D, Hughes LE.
    Clin Oncol; 1980 Jun 30; 6(2):159-66. PubMed ID: 7408283
    [No Abstract] [Full Text] [Related]

  • 12. Phase II randomized study of interleukin-2 with or without 13-cis retinoic acid as maintenance therapy in patients with advanced cancer responsive to chemotherapy.
    Recchia F, Saggio G, Cesta A, Alesse E, Gallo R, Necozione S, Rea S.
    Anticancer Res; 2005 Jun 30; 25(4):3149-57. PubMed ID: 16080579
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Immunosuppression: a paraneoplastic syndrome].
    Nagel GA.
    Schweiz Med Wochenschr; 1971 Apr 03; 101(13):470-4. PubMed ID: 5283773
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The use of a whey protein concentrate in the treatment of patients with metastatic carcinoma: a phase I-II clinical study.
    Kennedy RS, Konok GP, Bounous G, Baruchel S, Lee TD.
    Anticancer Res; 1995 Apr 03; 15(6B):2643-9. PubMed ID: 8669840
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Improvement of phytohemagglutinin responsiveness of lymphocytes from cancer patients after washing in vitro.
    Mannick JA, Constantian M, Pardrige D, Saporoschetz I, Badger A.
    Cancer Res; 1977 Sep 03; 37(9):3066-70. PubMed ID: 884664
    [No Abstract] [Full Text] [Related]

  • 19. [Studies on immunosuppression in the patient with lung cancer: character and function of lymphocytes (author's transl)].
    Inoue S.
    Hokkaido Igaku Zasshi; 1982 Jan 03; 57(1):87-100. PubMed ID: 7076110
    [No Abstract] [Full Text] [Related]

  • 20. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.
    Schmielau J, Finn OJ.
    Cancer Res; 2001 Jun 15; 61(12):4756-60. PubMed ID: 11406548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.